President
Dr. Stella K. Kim is the Joe M. Green Jr. Professor of Clinical Ophthalmology at UTHealth Medical School. Dr. Kim spent 10 years at Harvard Medical School, obtaining her medical degree, and completing Grunebaum Cancer Research Fellowship and Howard Hughes Medical Institute Medical Student Research fellowship, followed by a medical internship, and ophthalmology residency at the Massachusetts Eye and Ear Infirmary.
As a Heed fellow, Dr. Kim completed a fellowship in cornea, refractive, and external diseases at the Moran Eye Center/University of Utah. She joined faculty at the University of Texas M.D.Anderson Cancer Center and spent approximately 13 years caring for patients with systemic and ocular malignancies, teaching residents and medical students from UTMB and UTHealth, directing Clinical Research in Ophthalmology, and participating in national and international extramural activities with AAO, ARVO, ABO, ASCO among others. She is a founding member of the International Chronic Ocular Graft vs. Host Disease (GVHD) Consensus, and Dr. Kim’s work in this and other areas in ocular toxicity of cancer therapy is internationally recognized.
Dr. Kim joined UTHealth Medical School/Cizik Eye Clinic in 2014, and she continues to enjoy patient care, teaching and clinical research. Her clinical practice includes medical and surgical care of patients with ocular surface diseases, including ocular surface neoplasia, ocular toxicity of cancer therapy (including ocular GVHD) and other pathology of cornea, cataract, and external diseases.
As a Heed fellow, Dr. Kim completed a fellowship in cornea, refractive, and external diseases at the Moran Eye Center/University of Utah. She joined faculty at the University of Texas M.D.Anderson Cancer Center and spent approximately 13 years caring for patients with systemic and ocular malignancies, teaching residents and medical students from UTMB and UTHealth, directing Clinical Research in Ophthalmology, and participating in national and international extramural activities with AAO, ARVO, ABO, ASCO among others. She is a founding member of the International Chronic Ocular Graft vs. Host Disease (GVHD) Consensus, and Dr. Kim’s work in this and other areas in ocular toxicity of cancer therapy is internationally recognized.
Dr. Kim joined UTHealth Medical School/Cizik Eye Clinic in 2014, and she continues to enjoy patient care, teaching and clinical research. Her clinical practice includes medical and surgical care of patients with ocular surface diseases, including ocular surface neoplasia, ocular toxicity of cancer therapy (including ocular GVHD) and other pathology of cornea, cataract, and external diseases.
